Terug
34
Dagbereik
€ 18,17
€ 20,43
52-Weeksbereik
€ 14,09
€ 21,22
Volume
24
50D / 200D Gem.
€ 18,17
/
€ 19,03
Vorige Slotkoers
€ 18,17
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 0,2 |
| P/B | 0,0 | 3,0 |
| ROE % | 10,6 | 3,6 |
| Net Margin % | 5,2 | 3,8 |
| Rev Growth 5Y % | 17,5 | 9,9 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 195,59
€ 191,17 – € 199,53
|
1,26T | 1 |
| FY2029 |
€ 185,85
€ 181,64 – € 189,59
|
1,23T | 1 |
| FY2028 |
€ 162,15
€ 158,48 – € 165,42
|
1,21T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-13 | € 42,39 | € 0,26 | -99,4% |
| 2025-11-12 | € 0,22 | € 0,23 | +4,0% |
| 2025-08-11 | € 0,24 | € 0,22 | -6,7% |
| 2025-05-08 | € 0,19 | € 0,23 | +22,6% |
| 2025-02-12 | € 0,25 | € 0,26 | +1,9% |
| 2024-11-14 | € 0,24 | € 0,22 | -7,4% |
| 2024-08-13 | € 0,19 | € 0,17 | -9,4% |
| 2024-05-10 | € 0,17 | € 0,16 | -4,2% |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
0,31%
Growth (3Y)
-17,59%
Growth (5Y)
-13,59%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Jun 01, 2026 | € 0,17 | 1,80% |
| Sep 30, 2025 | Dec 02, 2025 | € 0,16 | 1,66% |
| Mar 31, 2025 | Jun 23, 2025 | € 0,15 | 2,14% |
| Sep 30, 2024 | Dec 03, 2024 | € 0,15 | 1,63% |
| Mar 28, 2024 | Jun 24, 2024 | € 0,13 | 1,42% |
| Sep 28, 2023 | Dec 04, 2023 | € 0,33 | 1,81% |
| Mar 30, 2023 | Jun 26, 2023 | € 0,34 | 1,65% |
| Sep 29, 2022 | Dec 02, 2022 | € 0,28 | 1,51% |
| Mar 30, 2022 | Jun 29, 2022 | € 0,29 | 1,48% |
| Sep 29, 2021 | Dec 02, 2021 | € 0,31 | 1,59% |
| Mar 30, 2021 | Jun 30, 2021 | € 0,32 | 1,41% |
| Sep 29, 2020 | Dec 02, 2020 | € 0,33 | 1,61% |
| Mar 30, 2020 | Jun 29, 2020 | € 0,32 | 1,59% |
| Sep 27, 2019 | Dec 03, 2019 | € 0,32 | 1,57% |
| Mar 27, 2019 | Jun 28, 2019 | € 0,32 | 1,43% |
| Sep 26, 2018 | Dec 04, 2018 | € 0,27 | 1,34% |
| Mar 28, 2018 | Jun 29, 2018 | € 0,28 | 1,24% |
| Sep 27, 2017 | Dec 05, 2017 | € 0,44 | 1,48% |
| Mar 29, 2017 | Jun 30, 2017 | € 0,45 | 1,82% |
| Sep 28, 2016 | Dec 05, 2016 | € 0,45 | 1,63% |
Belangrijkste Punten
Revenue grew 17,50% annually over 5 years — strong growth
ROE of 10,56% — decent returns on equity
Debt/Equity of 0,00 — conservative balance sheet
Generating 67,01B in free cash flow
P/E of 0,13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 13,68%
Groei
Revenue Growth (5Y)
17,50%
Revenue (1Y)3,82%
Earnings (1Y)4,45%
FCF Growth (3Y)19,01%
Kwaliteit
Return on Equity
10,56%
ROIC11,77%
Net Margin5,15%
Op. Margin7,73%
Veiligheid
Debt / Equity
0,00
Current Ratio2,24
Interest Coverage1282,53
Waardering
P/E Ratio
0,13
Forward P/E0,13
P/B Ratio0,01
EV/EBITDA-1,25
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,82% | Revenue Growth (3Y) | 5,64% |
| Earnings Growth (1Y) | 4,45% | Earnings Growth (3Y) | 16,13% |
| Revenue Growth (5Y) | 17,50% | Earnings Growth (5Y) | 26,13% |
| Profitability | |||
| Revenue (TTM) | 1,06T | Net Income (TTM) | 54,68B |
| ROE | 10,56% | ROA | 7,67% |
| Gross Margin | 35,06% | Operating Margin | 7,73% |
| Net Margin | 5,15% | Free Cash Flow (TTM) | 67,01B |
| ROIC | 11,77% | FCF Growth (3Y) | 19,01% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 2,24 |
| Interest Coverage | 1282,53 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,31% |
| Dividend Growth (3Y) | -17,59% | Dividend Growth (5Y) | -13,59% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,13 | Forward P/E | 0,13 |
| P/B Ratio | 0,01 | P/S Ratio | 0,01 |
| PEG Ratio | 2,32 | Forward PEG | N/A |
| EV/EBITDA | -1,25 | Fwd EV/EBITDA | -0,66 |
| Forward P/S | 0,01 | Fwd Earnings Yield | 769,23% |
| FCF Yield | 926,84% | ||
| Market Cap | 7,23B | Enterprise Value | -102,31B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,06T | 1,02T | 951,25B | 729,97B | 556,91B |
| Net Income | 54,68B | 52,35B | 40,55B | 34,38B | 21,60B |
| EPS (Diluted) | 133,81 | 125,27 | 95,99 | 93,78 | 70,12 |
| Gross Profit | 372,24B | 331,80B | 329,32B | 240,30B | 182,10B |
| Operating Income | 82,08B | 75,71B | 62,28B | 41,41B | 31,53B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 712,78B | 724,75B | 688,13B | 656,74B | 368,92B |
| Total Liabilities | 191,28B | 209,57B | 205,42B | 192,40B | 122,46B |
| Shareholders' Equity | 520,80B | 514,73B | 482,47B | 464,32B | 246,46B |
| Total Debt | 2,21B | 20,66B | 21,41B | 22,92B | 23,70B |
| Cash & Equivalents | 111,75B | 117,72B | 95,22B | 74,52B | 38,52B |
| Current Assets | 364,32B | 370,80B | 329,81B | 304,39B | 175,70B |
| Current Liabilities | 162,64B | 179,43B | 153,27B | 142,45B | 84,89B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#582 of 826
Recente Activiteit
Uitgestapt
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026